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Abstract
Background:  Research on the effects of treating sub-threshold depression in persons with
diabetes is scarce in spite of the findings indicating that this condition is highly prevalent in the
diabetic population and may increase the risk of developing a subsequent major depression. This
study was aimed at exploring the effects of a psycho-educational intervention on depression- and
diabetes-related outcomes in patients with mild to moderate depressive symptoms.
Methods: A randomized controlled study design with a one-year follow-up was used. Fifty patients
with mild to moderate depressive symptoms (74% female, aged 57 ± 9 yrs, diabetes duration of 10
± 8 yrs, BMI 31 ± 6 kg/m2, HbA1C 7.7% ± 1.4, 53% insulin treated) were randomly assigned to
either an intervention or a control group. The intervention group underwent four psycho-
educational sessions aimed at enabling self-management of depressive symptoms. The control
group was informed about the screening results and depression treatment options while continuing
diabetes treatment as usual. Both groups were contacted by phone in 2–3-month intervals, and re-
assessed for depression after 6 and 12 months. Changes in depressive symptoms and glycaemic
control were considered primary outcomes. Mann-Whitney U test and Friedman ANOVA were
used to compare between- and within-group indicators at 6- and 12-month follow-ups.
Results: Both the intervention and the control group reported a significant decrease in depressive
symptoms as measured by the CES-D scale (Friedman ANOVA χ2 = 10.8 p = .004 and χ2 = 7.3 p
= 0.03, respectively). The 6-month and 1-year indicators of glycaemic control as compared to
baseline HbA1C values were also improved in both groups (χ2 = 11.6 p = 0.003 and χ2 = 17.1 p =
0.0002, respectively). Between-group differences in depressive symptoms and HbA1C values were
not statistically significant either at 6- or at 12-month follow-up (all p > 0.05).
Conclusion: Psycho-educational treatment appears to be beneficial in diabetic patients with mild
to moderate depressive symptoms, but its effects are comparable with the non-specific support
given to the subjects in the control group.
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Background
The prevalence of depression in diabetes is approximately
twice as high as in the general population [1], implying a
synergistic interaction between the two conditions that
increases the risk of poor health outcomes [2].
In comparison with patients with diabetes alone, patients
with both diabetes and depression have been shown to
have poorer self-management (i.e. adherence to diet, exer-
cise regimen and blood glucose monitoring) and signifi-
cantly more lapses in refilling oral hypoglycaemic, lipid-
lowering and antihypertensive prescriptions [3,4].
Depressed patients with diabetes are also significantly
more likely to have cardiac risk factors such as smoking,
obesity and sedentary lifestyle, compared to those with
diabetes alone [5]. Depression is associated with an
increased risk of metabolic dysregulation [6], micro- and
macrovascular complications [7], and mortality [8].
Not only clinical depression but also its sub-threshold
forms have been shown to have a profound influence on
the affected patients' quality of life [9]. Defined as the
presence of depressive symptoms that fall short of full
diagnostic criteria for major depression or dysthymia,
sub-threshold depression may be considered to be a part
of a continuum of depressive disorders [10]. Judd et al.
[11] conceptualized unipolar depression as presenting in
different degrees of severity along a spectrum, with sub-
threshold depression being the mildest form along the
spectrum. It may represent a discrete category of its own
but may also represent a prodromal, residual or interepi-
sode symptomatic state in the course of major depression
[12]. Data from the general population indicate that
spontaneous improvement for this type of depression is
low [13]. A systematic review of the literature on the prog-
nosis of minor depression [14] showed that 16–62.3%
individuals with sub-threshold depressive symptoms still
have a minor depression after 5 months to 1 year of fol-
low-up, suggesting that for many people this form of
depression is chronic or recurrent. Sub-threshold depres-
sion has been found to increase the risk of subsequent
major depression [15] and suicide [16]. Recent studies
have uncovered some predictors of conversion from
minor depression into its more severe clinical forms,
chronic illness and medical burden being shown to be
among them [17,18].
As research on treatments for sub-threshold depression in
diabetic patients is scarce, data on their hypothetical
effects on depression- and diabetes-related outcomes are
inconclusive. There has been only one small randomized
placebo-controlled pilot study of pharmacological treat-
ment conducted in 15 mildly depressed women with type
2 diabetes [19], its results indicating beneficial treatment
effects on insulin sensitivity. A small non-randomized
study of the effects of a psycho-educational intervention
on mood and glycaemic control in adults with diabetes
and visual impairment [20] has shown positive effects on
diabetes-related distress as measured by the Problem
Areas in Diabetes scale, and on glycaemic control. The
study has demonstrated significant positive correlation
between glycaemic control and improvement in depres-
sion. Both of these studies have employed small sample
sizes and study designs that do not allow reliable conclu-
sions about the clinical benefits of treating sub-threshold
depression in persons with diabetes.
The hypothesis of this study was that screening depressive
symptoms in diabetic patients attending their regular
medical check-ups, and including those with sub-thresh-
old depression in a psychoeducational intervention
accompanied by a structured follow-up, might have posi-
tive effects on depression- and diabetes-related outcomes
as defined as improvement of depressive symptoms and
glycaemic control. The study was expected to remedy
methodological inadequacies inherent to previous studies
in the field using a randomized controlled study design
with a one-year follow-up. It was aimed at comparing the
effects of the psycho-educational intervention in diabetic
patients with mild to moderate depressive symptoms with
those of standard diabetes care including screening for
depression and a structured follow-up.
In this paper we present baseline and one-year follow-up
data of 50 patients randomly assigned to the two groups.
Methods
Diabetic patients attending their regular check-ups at the
Vuk Vrhovac University Clinic for Diabetes, Endocrinol-
ogy and Metabolic Diseases, a referral centre for the regis-
tration, treatment and follow-up of patients with diabetes
in Croatia, were screened for depression by using the
Patient Health Questionnaire (PHQ-9). Patients with
scores of 10–14 points, which indicated mild to moderate
depression [21], were the trial's target group. A history of
poor literacy, mobility difficulties, visual impairment,
drinking problems, co-morbid organic psychiatric disor-
der or psychosis was considered as the exclusion criteria.
The eligible patients were explained the purpose of the
study and requested to give written consent to participate.
Patients who were willing to be included were rand-
omized to either the intervention or the control group by
means of sequentially numbered sealed envelopes.
Patients who refused to participate in the research
received their usual diabetes care and were excluded from
this study.
Participants in the intervention arm were included in a
psycho-educational programme consisting of four interac-Trials 2009, 10:78 http://www.trialsjournal.com/content/10/1/78
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tive group sessions. The control subjects continued to
receive standard diabetes care while being informed about
the outcomes of the performed screening procedure, and
about available treatment modalities. Both groups were
followed for one year including re-assessments of depres-
sive symptoms and glycaemic control at 6 and 12 months,
and telephone calls in 2- to 3-month intervals to check on
patients' actions in managing depression.
At baseline, the study participants were interviewed using
a semi-structured interview inquiring about their psycho-
logical history (past psychological morbidity, method of
treatment, course of symptoms, psychological morbidity
in family members) and present psychosocial situation
(family status, professional status, economic circum-
stances, recent stressful experiences, perceived social sup-
port).
Psychological questionnaires Center for Epidemiologic
Studies Depression Scale [22], Problem Areas in Diabetes
[23] scale, health-related quality of life questionnaire [24]
and Summary of Diabetes Self-Care Activities [25] were
applied to collect data about patients' emotional state and
their experience in living with diabetes. The question-
naires were previously psychometrically evaluated in
Croatian diabetic patients.
The Centre for Epidemiological Studies Depression (CES-
D) scale is a 20-item, self-report scale that asks respond-
ents to indicate the frequency of experiencing each of the
20 symptoms over the previous week. The instrument uses
a 4-point response scale ranging from "rarely or none of
the time" to "most or all of the time" with total scores
ranging from 0 to 60. Higher scores indicate more severe
depressive symptoms. A cut-point of ≥ 16 was considered
indicative of elevated depressive symptoms.
The Problem Areas in Diabetes (PAID) questionnaire is a
20-item, self-report scale that asks respondents to rate
how much of a problem they find each of the 20 diabetes-
related issues. The answers are given on a 5-point scale
ranging from 0 ("not a problem") to 4 ("serious prob-
lem"). The PAID scores are summed (with total scores
ranging from 0 to 80) and transformed to a 0–100 scale
with higher scores indicating more diabetes-related dis-
tress. Scores > 40 were considered indicative of high dis-
tress.
The short-form health survey (SF-12 v2) comprises self-
assessments of general health, physical functioning, phys-
ical roles, bodily pain, vitality, social functioning, emo-
tional roles and mental health. The raw scores for
particular subscales are transformed to a 0–100 scale with
higher scores indicating better health-related quality of
life.
The Summary of Diabetes Self-Care Activities (SDSCA) is
a brief self-report questionnaire of diabetes self-manage-
ment that includes items assessing general diet, specific
diet, exercise, blood glucose testing, foot care and smok-
ing. The questionnaire asks the respondents about the fre-
quency with which they performed self-care activities over
the previous 7 days. Higher subscale scores indicate more
regular performing of the self-care activities included.
Medical data were collected from the patients' medical
records. HbA1c was determined by an automated immu-
noturbidimetric method using Bayer reagents (Tarrytown,
Il, USA) on Olympus AU600 analyser (Olympus Optical
Co., Tokyo, Japan) with a normal range from 3.5 to 5.7%
[26].
The intervention arm
Psycho-education on depression
The psycho-educational intervention comprised 4 interac-
tive small group meetings, each lasting for 90 minutes, on
the following topics:
￿ Symptoms of depression; interaction of depression and
diabetes;
￿ Alleviating burden of depression through activities and
problem solving;
￿ Associations between depression and cognitive proc-
esses – thoughts, beliefs and attitudes that induce and
maintain depression; and
￿ Developing a personal plan for managing depression-
related problems in the future.
The first two meetings were held within a week of each
other, and the third and the fourth at two-week intervals.
Patients were provided with a self-help manual for over-
coming depressive difficulties based on the "Coping with
depression" course by P.M. Lewinsohn [27,28]. The man-
ual was given to the participating patients prior to the first
session in order to make them familiar with the course
contents and to facilitate reflecting their own experiences.
The manual's structure aimed to stimulate introducing
personal examples and making notes. The group sessions
consisted of discussing particular topics rather than listen-
ing about them. A part of the manual was a workbook
containing exercises to recognize depressive symptoms,
become aware of daily activity patterns, plan more pleas-
urable activities, solve problems by using a four-step
approach, and to recognize and modify cognitive patterns
that contribute to maintenance of depression. The exer-
cises were planned as homework. It included keeping
mood and daily activities diary, planning daily activities
to include more enjoyable ones, practicing a problemTrials 2009, 10:78 http://www.trialsjournal.com/content/10/1/78
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solving technique to manage personal problems the
patients were faced with, and using the acquired knowl-
edge to improve self-awareness, primarily with respect to
automatic negative thoughts that worsen the depressive
mood. The patients' experiences in going through the
homework were discussed at the beginning of the subse-
quent session.
The manual was tested for comprehensibility and clarity
in a group of diabetic patients (N = 8) with different
demographic and disease-related characteristics. For the
purpose of this study, the programme was partially mod-
ified and adjusted to diabetes-specific emotional prob-
lems.
The control arm
Depression screening followed by standard diabetes treatment
The patients screened for depression demonstrating ele-
vated result were given explanation of their result and
were informed about available treatment options. The
control participants were contacted by phone at the same
intervals as the patients from the intervention group, and
re-assessed for psychological variables after 6 and 12
months.
Sample size calculation was based on the absolute change
in depressive symptoms as measured by the CES-D ques-
tionnaire from the run-in period to the 6- and 12-month
follow-up assessments. To demonstrate a clinically mean-
ingful difference in the CES-D scores with alpha = 0.05
and power of 90%, and assuming a common standard
deviation of the CES-D scores of 8.4, 94 patients would be
needed in each group.
These preliminary results were analysed using non-para-
metric statistics including medians and modes to describe
measures of central tendencies and variability, Mann-
Whitney U test to determine between-group differences at
the three measurement points, and the Friedman ANOVA
test to determine within-group differences in depression-
related and metabolic outcomes.
Ethical approval
The study was approved by the Vuk Vrhovac Clinic Ethics
committee.
Results
Demographic, disease-related and psychological charac-
teristics of the intervention and the control group are pre-
sented in Table 1. The two groups were comparable with
Table 1: Demographic, disease-related and psychological characteristics of the patients from the intervention and the control groups
Intervention group
Median (25–75)
Control group
Median (25–75)
Zp
Age (yrs) 55 (51–62) 58 (53–64) -1.1 0.27
Female (%) 64 84 0.11
Education (yrs) 12 (8–14) 11 (8–11) 2.52 0.01**
Diabetes duration (yrs) 10 (3–14.5) 10.5 (4.5–13.5) -0.51 0.61
Body mass index (kg/m2) 30.8 (26.7–35.8) 30.9 (27.9–30.4) 0.25 0.80
HbA1C (%) 7.5 (6.4–8.3) 7.7 (6.6–8.9) -0.42 0.68
PHQ-9 (score) 13 (11–18) 13 (11–15) 0.23 0.81
CES-D (score) 26 (22–30) 24 (18–35) 1.03 0.31
PAID (total score) 51 (33–60) 45 (25–58) 0.91 0.36
Negative emotions 56 (33–67) 48 (21–63) 0.86 0.40
Treatment 33 (17–50) 33 (17–50) -0,23 0.82
Food 42 (33–75) 58 (33–75) -0.03 0.98
Social support 38 (13–63) 13 (0–50) 1.49 0.14
SDSCA-diet 4 (3–6) 4 (3–6) 0.07 0.94
-specific diet 3.5 (2–5.5) 5.5 (3.5–7) -2.11 0.03*
-exercise 3.25 (1.5–5) 3 (1–3.5) 0.75 0.43
-blood glucose monitoring 7 (0.75–5.25) 6.5 (0.5–7) 0.69 0.49
-foot care 3.5 (0–7) 2.5 (0–7) 0.51 0.61
SF – General health 25 (0–25) 25 (0–50) -0.06 0.95
Physical functioning 37.5 (25–50) 17 (0–37.5) 2.36 0.02*
Role physical 50 (25–62.75) 50 (31.25–62.5) 0.08 0.94
Role emotional 50 (50–50) 50 (32–62.5) -0.30 0.77
Bodily pain 50 (25–62.5) 25 (25–75) -0.05 0.96
Mental health 38 (25–50) 38 (25–50) -0.45 0.65
Vitality 25 (25–50) 50 (25–50) -1.22 0.22
Social functioning 37.5 (25–50) 50 (25–75) -1.78 0.07
** significant at 99% confidence level
* significant at 95% confidence levelTrials 2009, 10:78 http://www.trialsjournal.com/content/10/1/78
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respect to age, gender, diabetes duration, body mass
index, glycaemic control, depressive symptoms and diabe-
tes-related emotional problems (all p > 0.05). Health-
related quality of life was comparable in both groups with
the exception of physical functioning which was shown to
be slightly better in the intervention group (p = 0.02).
Self-reported diabetes self-care was similar in both groups
with respect to healthy eating, exercise, blood glucose self-
monitoring and foot care (all p > 0.05). Adherence to dia-
betes-specific diet seemed to be greater in the control
group (p = 0.03). The intervention group had a higher
level of education than the control group (p = 0.01).
Between-group differences at the 6- and 12-month follow-
up visits are presented in Table 2.
Both the intervention and the control group reported less
depressive symptoms at the follow-up assessments and
had better glycaemic control as compared to baseline
indicators. The between-group differences were not statis-
tically significant either at 6- or at 12-month follow-ups.
Changes in depressive symptoms and HbA1C values for
the intervention group are presented in Figures 1 and 2.
Friedman ANOVA indicated that individuals treated with
psycho-educational intervention reported improved
depressive symptoms at the 6-month assessment and
remained so after 12 months (p = 0.004). The same trend
could be observed for HbA1C values which were signifi-
cantly lower at the follow-up assessments, showing an
average decrease of 0.5% (p = 0.0003).
Changes in depression-related outcomes and glycaemic
control for the control group are presented in Figures 3
and 4. Like the intervention group, the control subjects
improved their depressive symptoms and HbA1C at 6-
and 12-month follow-up assessments (p = 0.03 and p =
0.0002 respectively).
Discussion
The preliminary data on the effects of the psycho-educa-
tional intervention in patients with mild to moderate
depressive symptoms do not support its effectiveness in
comparison with the non-specific support given to the
control patients. A comparable improvement in depres-
sive symptoms observed in the patients who were
included in the psycho-educational group sessions, and in
those who were only screened for depression and then fol-
lowed for one year might suggest that treating sub-thresh-
old forms of depression does not demonstrate a clear
clinical utility. Such a conclusion might be additionally
supported by the finding that both the intervention and
the control participants demonstrated a similar improve-
ment in glycaemic control at 6- and 12-month follow-up
assessments. These findings suggest that the patients
included in the study benefited in terms of improved
mood and glycaemic control regardless of the study arm.
There are two hypothetical explanations of the results
obtained. The first one concerns the structure of the con-
trol arm. Although defined as "diabetes treatment as
usual" it actually implied a more supportive approach
than diabetic patients usually receive within their stand-
ard care. Screening for depression and discussing the
results with the patients may be considered a kind of an
intervention as well. As shown by Pouwer et al. [29], mon-
itoring and discussing psychological well-being as part of
routine diabetes outpatient care had favourable effects on
the patients' mood. Besides monitoring, the control par-
ticipants in our trial received several telephone calls dur-
ing the follow-up period, and were invited for depression
reassessment after 6 and 12 months. This could have been
experienced as an additional support possibly affecting
the obtained results. Qualitative data on patients' experi-
ences with participating in the trial collected at the end of
the follow-up period support the hypothesis on the bene-
ficial effect of monitoring patients' mood within standard
diabetes care.
Table 2: Comparisons of depressive symptoms and glycaemic control between the intervention and the control group at 6 and 12 
months
Absolute change: Intervention versus Control group U z p
Depressive symptoms at 6 months (CES-D scores) 26 (22–30) to 18 (12.5–28.5) versus 24 (18–35) to 20 
(16.5–27)
264.5 -0.49 0.63
Depressive symptoms at 12 months (CES-D scores) 26 (22–30) to 19(11–26) versus 24 (18–35) to 19 (15–26) 295.5 -0.33 0.74
Glycaemic control at 6 months (HbA1C) 7.5 (6.4–8.3) to 7.3 (6.3–7.6) versus 7.7 (6.6–8.9) to 6.9 
(6.2–8.2)
279.0 0.19 0.86
Glycaemic control at 12 months (HbA1C) 7.5 (6.4–8.3) to 7.0 (6.0–7.6) versus 7.7 (6.6–8.9) to 7.0 
(5.9–7.9)
293.5 -0.13 0.89Trials 2009, 10:78 http://www.trialsjournal.com/content/10/1/78
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The second explanation of the obtained results concerns
the intervention format and content. A short intervention
used in the trial relied on cognitive-behavioural princi-
ples. It aimed to stimulate patients' activation and
improve their capabilities to actively participate in solving
their internal and external problems. However, some indi-
viduals found participation in group sessions and exer-
cises difficult. Possibly due to their demographic
characteristics (middle age, relatively low level of educa-
tion, limited objective resources) they perceived engage-
ment in psychological processes they had not previously
practiced as difficult. Their ambivalence towards experi-
menting with new cognitive patterns might be even
increased by the fact that, although agreeing to the inter-
vention, they actually would not choose it if it were not
recommended. Being asked about subjectively perceived
benefits of the intervention at the end of the follow-up,
some patients pointed out the new skills they learned, but
the majority found the experienced support to be most
helpful.
Qualitative data collected from the intervention and the
control subjects allow a hypothesis that the two study
arms had at least one common component, described by
the patients as a sense of being supported and cared for,
and that this component itself seems to be helpful in
addressing sub-threshold depression in patients with dia-
betes.
Another relevant finding obtained in the study was that
the intervention and the control groups comparably
improved HbA1C values after 6- and 12-month follow-up
periods indicating an inverse relation between depressive
symptoms and glycaemic control. At present, the relation-
ship between depressive symptoms and glycaemic control
is still not fully understood. Some studies have proved an
undesirable association between depressive symptoms
and metabolic indicators [6] but others did not confirm
such an association [30,31]. Effects of treating depressed
diabetic individuals on their glycaemic control are also a
matter of debate, with controversial reports on the associ-
ation between metabolic improvement and reduction in
depressive symptoms [32,33].
Our preliminary data suggest that focusing on patients'
emotional state either in the form of a psycho-educational
Depressive symptoms at baseline and after 6- and 12-month follow-up (Intervention arm) Figure 1
Depressive symptoms at baseline and after 6- and 12-month follow-up (Intervention arm). Χ2 = 10.8, p = 0.004, 
Coefficient of concordance = 0.27, Average rank correlation = 0.23.
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Depressive symptoms at baseline and after 6- and 12-month follow-up (Control arm) Figure 2
Depressive symptoms at baseline and after 6- and 12-month follow-up (Control arm). Χ2 = 7.3, p = 0.03, Coeffi-
cient of concordance = 0.19, Average rank correlation = 0.15.
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Glycaemic control at baseline and after 6- and 12-month follow-up (Intervention arm) Figure 3
Glycaemic control at baseline and after 6- and 12-month follow-up (Intervention arm). Χ2 = 11.6, p = 0.003, Coef-
ficient of concordance = 0.34, Average rank correlation = 0.30.
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intervention or in the form of monitoring and following-
up its further development, has positive effects on glycae-
mic control.
A limitation of this preliminary report is its smaller sam-
ple size than indicated by the power analysis. However,
the preliminary data trend and the qualitative indicators
of the patients' benefits gained from participating in the
trial make these findings worth reporting.
Although slightly different with respect to education, self-
reported adherence to diabetes-specific diet and self-
reported physical functioning, the two groups could be
considered basically comparable regarding disease-related
and psychological variables. In accordance with the litera-
ture [34], depressive symptoms in our study participants
frequently co-occurred with diabetes-related distress sug-
gesting that focus should be equally on monitoring
depressive symptoms and monitoring emotional distress
caused by diabetes.
Further research relying on bigger sample sizes is needed
to determine whether a psycho-educational intervention
may be more efficient than monitoring and following
well-being in patients with sub-threshold depression.
Inquiring into patients' beliefs about the necessity of treat-
ing sub-threshold depressive symptoms, and value-
weighted preferences regarding the treatment form may
be helpful in determining which patients benefit the
most.
Conclusion
Preliminary data of the randomized controlled trial aimed
at comparing the effects of a psycho-educational interven-
tion in patients with mild to moderate depressive symp-
toms with screening for depression accompanied by a
structured follow-up showed comparable improvements
in depression- and disease-related variables in both study
arms. The findings suggest that monitoring patients' well-
being within diabetes check-ups, and following those
with mild to moderate depressive symptoms could be suf-
ficient at these early stages of depression development.
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Glycaemic control at baseline and after 6- and 12-month follow-up (Control arm) Figure 4
Glycaemic control at baseline and after 6- and 12-month follow-up (Control arm). Χ2 = 17.1, p = 0.002, Coefficient 
of concordance = 0.45, Average rank correlation = 0.42.
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